ANIK Financial Facts
Selling, general & administrative: 3.95MNet income: 0.21
See Full Income Statement
Accumulated currency translation adjustment: -3.4M
Total current assets: 78.69M
See Full Balance Sheet
Earnings History for Anika Therapeutics Inc. (ANIK)
|
Expand Research on ANIK
| Next EPS Date | 5/1/13 *Est. | EPS Growth Rate | +47.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +17.8% | Revenue Growth Rate | +22.8% *Last Qtr. |
| Average % Move 1-Wk after EPS | +12.7% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/27/13 |
Q412 | $0.31 | $0.25 | +$0.06 | $22.6M | $21.59M | N/A / N/A | N/A | +34.9% | Details | |
| 10/30/12 |
Q312 | $0.11 | $0.17 | -$0.06 | $14.8M | $16.83M | N/A / N/A | N/A | +18.9% | Details | |
| 5/3/12 | Q112 | $0.14 | $0.17 | -$0.03 | $14.4M | $18.2M | N/A / N/A | N/A | -13.1% | Details | |
| 2/29/12 |
Q411 | $0.21 | N/A | N/A | $18.4M | $14.7M | N/A / N/A | N/A | 0% | Details | |
| 11/2/11 |
Q311 | $0.22 | $0.11 | +$0.11 | $18.5M | $15.1M | N/A / N/A | N/A | +139.2% | Details | |
| 8/4/11 |
Q211 | $0.17 | N/A | N/A | $16.1M | $13.7M | N/A / N/A | N/A | +141.6% | Details | |
| 5/4/11 |
Q111 | $0.02 | N/A | N/A | $11.7M | N/A | N/A / N/A | N/A | +75.6% | Details | |
| 3/9/11 |
Q410 | $0.10 | N/A | N/A | $14.2M | N/A | N/A / N/A | N/A | +63.5% | Details |
